I would like to switch gears a little and discuss the costs of immuno-oncology agents. Currently, the treatment cost for immuno-oncology agents is exceedingly high and not affordable for many patients. For example, the treatment cost for Nivolumab is estimated at $104,000 per year or $9,000 per month. The FDA will likely approve Nivolumab for the treatment of advanced RCC sometime next year. This means Medicare will cover the majority of the costs associated with this drug; however, even a 20% copay would amount to a $20,000 out of pocket cost for the patient. Could the authors and experts comment on the high cost associated with immuo-oncology agents?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this challenge
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.